Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin Repurposing in RRMS
NCT05298670Phase 2Unknown
- Sponsor
- German University in Cairo
- Start
- Feb 2022
- Primary completion
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of liquid metformin (Aspargo Labs) in multiple sclerosis (MS), sponsored by German University in Cairo. Status: unknown.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT05298670.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05298670.